Frank Morschhauser

32 papers receiving 1.5k citations

Frank Morschhauser's Hit Papers

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma 2021 · 178 citations
1780+1+3Years since publication50100150

Peers

Frank Morschhauser
Comparison fields: 5 of 52
  • Pathology and Forensic Medicine 1.1k
  • Genetics 239
  • Oncology 563
  • Hematology 199
  • Neurology 223
Replace Marianne Engelhard with:
Marianne Engelhard Germany
Jane A. Estell Australia
Jocelyn C. Maragulia United States
Monika Długosz‐Danecka Poland
Pip Patrick United Kingdom
Charles Foussard France
M. Dreyling Germany
Olivier Fitoussi France
Heidi Móciková Czechia
Andrew Haynes United Kingdom
Frank Morschhauser relative to Marianne Engelhard Germany Marianne Engelhard's profile →
Citations per field
00.5×1.5×2×2.5×
Marianne Engelhard · 1×
Citations per year

Countries citing papers authored by Frank Morschhauser

Since Specialization
Citations

This map shows the geographic impact of Frank Morschhauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Morschhauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Morschhauser more than expected).

Fields of papers citing papers by Frank Morschhauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Morschhauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Morschhauser. The network helps show where Frank Morschhauser may publish in the future.

Co-authors

The 25 scholars most cited alongside Frank Morschhauser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Morschhauser Line = papers co-authored together Frank Morschhauser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014285
2 2008205
3
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
Hit paper breakdown →
2021178
4 2006123
5 2005105
6 201691
7 201777
8 201176
9 201374
10 201273
11 200067
12 201643
13 201231
14 200526
15 201421
16
Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma.
201211
17 200210
18 20214
19
IMPACT OF PRIOR TREATMENT ON PFS FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PATIENTS RANDOMIZED TO LENALIDOMIDE VS INVESTIGATOR'S CHOICE: A SUBGROUP ANALYSIS OF THE PHASE II MCL-002 (SPRINT) STUDY
20153
20 20183

About Frank Morschhauser

Frank Morschhauser is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (4 papers), Viral-associated cancers and disorders (4 papers), Acute Myeloid Leukemia Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Genetics (239 citations), Oncology (563 citations), Hematology (199 citations) and Neurology (223 citations). Frank Morschhauser has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include René-Olivier Casasnovas, Pierre Feugier, Réda Bouabdallah, Corinne Haïoun, Pierre Fenaux, Claude Preudhomme, Gilles Salles, Luc Xerri, Daniel Olive and Jean Michel Picquenot. Their work appears in journals such as Hematological Oncology, Haematologica, Blood, Journal of Clinical Oncology and European Journal of Nuclear Medicine and Molecular Imaging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact